Pacemaker treatment after Fontan surgery-A Swedish national study.
Jenny Alenius DahlqvistJan SunnegårdhKatarina HanséusEva Strömvall LarssonAnders NygrenMagnus DalénHåkan BerggrenJens Johansson RamgrenUrban WiklundAnnika RydbergPublished in: Congenital heart disease (2019)
Thirteen percent of Fontan patients received a permanent pacemaker, most frequently due to SND. EC was associated with a significantly lower prevalence of pacemaker than LT. Permanent pacemaker was more common in patients with MA, DORV, and DILV.
Keyphrases
- vena cava
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- risk factors
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- quality improvement
- coronary artery disease
- patient reported outcomes
- inferior vena cava
- percutaneous coronary intervention
- surgical site infection
- replacement therapy